Ecron Acunova CRO and Chulalongkorn University's Arm Form Joint Venture for Clinical Research in SEA
Ecron Acunova (EA), a CRO with presence in Europe and Asia, announced a joint venture with Jamjuree Innovations Co. Ltd., (JJI) Thailand. JJI is a 100% subsidiary of Chulalongkorn University Intellectual Property Foundation and enjoys strong ties with the University’s Faculty of Medicine, including Clinical Research Center (Chula CRC). The joint venture CRO is based in Bangkok and will conduct clinical research in key South East Asian countries under the name Ecron Acunova Company Ltd (EACL). Dr. Eugene Kroon MD is appointed CEO of EACL.
EA brings over two decades of clinical research experience in Ph I-IV trials, PK/PD services, clinical trial laboratory, and clinical data management on a global scale. EA has centers in oncology at Berlin, in diagnostic imaging agents in Frankfurt, and in stem cell therapy and diabetes at Bangalore. Chula CRC brings experience in PK/PD, clinical trial laboratory, data management, and HIV research in Thailand and SEA region.
Speaking on the joint venture, Dr. Kiat Ruxrungtham, Professor of Medicine, Chulalongkorn University and Chairman of EACL said, “We look forward to further expanding our model of hands-on local study and investigator relationship management in Southeast Asia for our clients through the joint venture with EA.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
